Correlation between hematological parameters and PET/CT metabolic parameters in patients with head and neck cancer [0.03%]
头颈部肿瘤患者血液学参数与PET/CT代谢参数相关性分析
Beat Bojaxhiu,Dubravko Sinovcic,Olgun Elicin et al.
Beat Bojaxhiu et al.
Background: Systemic inflammation is predictive of the overall survival in cancer patients and is related to the density of immune cells in the tumor microenvironment of cancer, which in turn correlates with 18F -fluorode...
Stereotactic radiosurgery for the treatment of brainstem metastases: a multicenter retrospective study [0.03%]
立体放射外科治疗脑干转移瘤的多中心回顾性研究
Luca Nicosia,Piera Navarria,Valentina Pinzi et al.
Luca Nicosia et al.
Background: Brainstem metastases (BSM) are associated with a poor prognosis and their management represents a therapeutic challenge. BSM are often inoperable and, in absence of randomized trials, the optimal radiation tre...
Multicenter Study
Radiation oncology (London, England). 2022 Aug 9;17(1):140. DOI:10.1186/s13014-022-02111-5 2022
Selection and validation of chemotherapy beneficiaries among elderly nasopharyngeal carcinoma (NPC) patients treated with intensity-modulated radiation therapy (IMRT): a large real-world study [0.03%]
基于大样本真实世界研究筛选并验证接受单纯放疗的鼻咽癌患者化疗获益人群
Yan-Ling Wu,Kai-Bin Yang,Ying Huang et al.
Yan-Ling Wu et al.
Purpose: Using real-world evidence, this study aimed to identify elderly nasopharyngeal carcinoma (NPC) patients who would benefit from chemotherapy. Meth...
The role of neoadjuvant radiochemotherapy in the management of localized high-grade soft tissue sarcoma [0.03%]
新辅助放化疗在局限性高级别软组织肉瘤治疗中的作用
Marta Kobus,Siyer Roohani,Felix Ehret et al.
Marta Kobus et al.
Background: Standard treatment of soft tissue sarcoma (STS) of the extremities includes limb-sparing surgery combined with pre- or postoperative radiotherapy (RT). The role of perioperative chemotherapy (CTX) remains unce...
Aggressive unifocal bone Langerhans cell histiocytosis with soft tissue extension both responsive to radiotherapy: a case report [0.03%]
放射治疗敏感的侵袭性骨朗格汉斯细胞组织细胞增生症并软组织侵犯1例报告
Wilmar Ghuijs,Paul G Kemps,Marta E Capala et al.
Wilmar Ghuijs et al.
Background: Langerhans cell histiocytosis (LCH) is a rare haematological neoplasm characterized by the accumulation of CD1a+, CD207/Langerin+ histiocytes within inflammatory lesions. LCH can involve any organ, but osteoly...
Effect of stomach size on organs at risk in pancreatic stereotactic body radiotherapy [0.03%]
胃大小对胰腺立体定向体放射治疗器官风险的影响
Osamu Tanaka,Takuya Taniguchi,Kousei Adachi et al.
Osamu Tanaka et al.
Background: In clinical practice, the organs at risk (OARs) should be carefully determined when performing pancreatic stereotactic body radiotherapy (SBRT). We conducted a simulation study to examine the effect of the sto...
Efficacy of concurrent chemoradiotherapy plus Endostar compared with concurrent chemoradiotherapy in the treatment of locally advanced nasopharyngeal carcinoma: a retrospective study [0.03%]
吉西他滨联合顺铂同期放化疗加恩度与单纯同期放化疗治疗局部晚期鼻咽癌的疗效回顾分析
Yuanxiu Yin,Ziyan Zhou,Zhiru Li et al.
Yuanxiu Yin et al.
Background: To retrospectively analyze the efficacy and safety of concurrent chemoradiotherapy (CCRT) plus recombinant human endostatin (Endostar, CCRT + E) versus CCRT alone in locally advanced nasopharyngeal carcinoma (...
Dose escalation based on 18F-FDG PET/CT response in definitive chemoradiotherapy of locally advanced esophageal squamous cell carcinoma: a phase III, open-label, randomized, controlled trial (ESO-Shanghai 12) [0.03%]
基于~(18)F-FDG-PET/CT疗效反应调整剂量用于不可手术食管鳞癌同期放化疗的III期开放性随机对照研究（ESO-Shanghai 12）
Hongcheng Zhu,Qiufang Liu,Hao Xu et al.
Hongcheng Zhu et al.
Introduction: Definitive chemoradiotherapy has established the standard non-surgical treatment for locally advanced esophageal cancer. The standard dose of 50-50.4 Gy has been established decades ago and been confirmed in...
Organs-at-risk dose constraints in head and neck intensity-modulated radiation therapy using a dataset from a multi-institutional clinical trial (JCOG1015A1) [0.03%]
头颈部调强放射治疗中风险器官剂量约束的限制（源自日本临床试验JCOG1015A1的数据集）
Masahiro Inada,Yasumasa Nishimura,Satoshi Ishikura et al.
Masahiro Inada et al.
Background: JCOG1015A1 is an ancillary research study to determine the organ-specific dose constraints in head and neck carcinoma treated with intensity-modulated radiation therapy (IMRT) using data from JCOG1015. ...
Multicenter Study
Radiation oncology (London, England). 2022 Jul 28;17(1):133. DOI:10.1186/s13014-022-02105-3 2022
Retrospective study of hypofractionated stereotactic radiotherapy combined with whole brain radiotherapy for patients with brain metastases [0.03%]
回顾性分析立体定向放疗联合全脑放疗治疗脑转移瘤患者的疗效及安全性
Xue-Yi Xie,Hong-Hua Peng,Xi Zhang et al.
Xue-Yi Xie et al.
Background and purpose: To evaluate the clinical outcomes of hypofractionated stereotactic radiotherapy (HFSRT) combined with whole brain radiotherapy (WBRT) in patients with brain metastases (BMs). ...